BioCentury
ARTICLE | Top Story

Takeda off after dropping fasiglifam

December 27, 2013 11:23 PM UTC

Takeda Pharmaceutical Co. Ltd. (Tokyo:4502) lost Y209.3 billion ($2 billion) in market cap on Friday after discontinuing development of fasiglifam ( TAK-875) due to concerns about liver safety. The fr...